Gimtype M3 Forte Tablet is an advanced oral antidiabetic formulation that combines Glimepiride, a sulfonylurea, and Metformin, a biguanide, in a bilayered sustained-release (SR) smart tablet. Glimepiride works by stimulating pancreatic beta cells to release insulin, thereby lowering blood glucose levels, while Metformin reduces hepatic glucose production, improves peripheral insulin sensitivity, and enhances glucose utilization by tissues. The bilayered sustained-release technology provides a controlled, prolonged release of Metformin for better glycemic stability, reduced gastrointestinal side effects, and improved patient compliance. This dual-action formulation targets both fasting and postprandial blood glucose, making it highly effective for comprehensive management of type 2 diabetes mellitus (T2DM).
Common side effects include mild hypoglycemia (due to Glimepiride), gastrointestinal disturbances such as nausea, diarrhea, abdominal discomfort (usually from Metformin), and headache. Rarely, severe hypoglycemia, lactic acidosis (especially in renal impairment), or allergic skin reactions can occur. Weight gain is possible due to sulfonylurea therapy, while Metformin may help mitigate it to some extent. Monitoring of blood glucose and renal function is essential during therapy.
Gimtype M3 Forte Tablet is indicated for the management of type 2 diabetes mellitus in adults when diet, exercise, and monotherapy with either Glimepiride or Metformin alone are insufficient to achieve optimal glycemic control. It helps in reducing the risk of diabetes-related complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disease.
Gimtype M3 Forte should be taken exactly as prescribed, preferably with meals to reduce the risk of hypoglycemia and gastrointestinal side effects. It is contraindicated in type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and in conditions predisposing to lactic acidosis. Caution is advised in elderly patients and those taking other hypoglycemic agents. Alcohol intake should be minimized as it increases the risk of hypoglycemia and lactic acidosis. Regular monitoring of blood sugar, HbA1c, renal and liver function is recommended. The medication should be continued along with proper diet and exercise as part of an overall diabetes management plan.
Store Gimtype M3 Forte Tablet in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date printed on the strip.